Valuation: Vertex Pharmaceuticals Incorporated

Market Cap 140B 120B 112B 103B 193B 13,374B 197B 1,323B 518B 6,708B 525B 514B 22,178B P/E 2026 *
32.6x
P/E 2027 * 26.6x
Enterprise Value 126B 108B 101B 92.5B 174B 12,031B 177B 1,190B 466B 6,034B 473B 462B 19,950B EV / Sales 2026 *
9.54x
EV / Sales 2027 * 8.34x
Free-Float
99.79%
Yield 2026 *
-
Yield 2027 * -
1 day+4.52%
1 week+5.01%
Current month+15.71%
1 month+13.67%
3 months+27.11%
6 months+17.64%
Current year+21.77%
1 week 502.29
Extreme 502.29
553.69
1 month 465
Extreme 465
553.69
Current year 412.27
Extreme 412.27
553.69
1 year 374.17
Extreme 374.17
553.69
3 years 340.83
Extreme 340.83
553.69
5 years 176.36
Extreme 176.36
553.69
10 years 71.46
Extreme 71.46
553.69
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2020
Director of Finance/CFO 57 10/04/2019
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Director/Board Member 66 01/01/1998
Chairman 70 01/05/2012
Director/Board Member 57 18/06/2015
Date Insider Type Main position Quantity % Market Cap.
21/07/26 Free

General Counsel

8,251 0.0033%
21/07/26 Free

Public Communications Manager

8,251 0.0033%
15/07/26 Free

Director

100 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+4.52%+5.01%+41.28%+60.10% 140B
+4.46%+4.92%+82.07%+134.31% 1,141B
+0.85%+4.81%+53.77%+58.51% 659B
+2.72%+6.92%+28.99%+77.15% 470B
+0.72%+2.32%+41.27%+45.77% 366B
+0.02%+2.81%+24.29%+41.36% 302B
-0.60%+2.51%+0.22%+12.44% 254B
+4.02%+6.29%+49.67%+68.96% 239B
+0.40%+0.77%-13.04%-52.34% 207B
+2.90%+8.63%+25.11%+94.52% 183B
Average +1.35%+4.19%+33.36%+54.08% 396.09B
Weighted average by Cap. +0.61%+4.33%+46.65%+73.69%

Financials

2026 *2027 *
Net sales 13.19B 11.31B 10.56B 9.69B 18.23B 1,261B 18.53B 125B 48.81B 632B 49.52B 48.45B 2,090B 14.58B 12.51B 11.68B 10.72B 20.15B 1,394B 20.49B 138B 53.98B 699B 54.76B 53.57B 2,312B
Net income 4.31B 3.69B 3.45B 3.16B 5.95B 412B 6.05B 40.69B 15.93B 206B 16.17B 15.81B 682B 5.22B 4.48B 4.18B 3.83B 7.21B 499B 7.33B 49.31B 19.31B 250B 19.59B 19.16B 827B
Net Debt -14.05B -12.06B -11.26B -10.33B -19.42B -1,343B -19.74B -133B -52.01B -674B -52.77B -51.62B -2,228B -18.18B -15.6B -14.57B -13.36B -25.13B -1,738B -25.54B -172B -67.3B -872B -68.28B -66.8B -2,882B
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
Date Price Change Volume
19/08/26 $552.06 +4.52% 1,437,713
18/08/26 $528.19 +2.45% 1,497,081
17/08/26 $515.55 +1.94% 1,111,401
14/08/26 $505.75 -2.07% 1,130,504
13/08/26 $516.44 -1.77% 863,530
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
552.06USD
Average target price
563.12USD
Spread / Average Target
+2.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VRTX Stock